Growth Metrics

Phibro Animal Health (PAHC) Short term Debt (2016 - 2025)

Phibro Animal Health has reported Short term Debt over the past 13 years, most recently at $20.6 million for Q4 2025.

  • Quarterly results put Short term Debt at $20.6 million for Q4 2025, up 27.0% from a year ago — trailing twelve months through Dec 2025 was $20.6 million (up 27.0% YoY), and the annual figure for FY2025 was $16.2 million, down 45.46%.
  • Short term Debt for Q4 2025 was $20.6 million at Phibro Animal Health, up from $18.4 million in the prior quarter.
  • Over the last five years, Short term Debt for PAHC hit a ceiling of $29.8 million in Q1 2024 and a floor of $4.8 million in Q3 2021.
  • Median Short term Debt over the past 5 years was $16.2 million (2024), compared with a mean of $17.7 million.
  • Biggest five-year swings in Short term Debt: soared 1152.65% in 2021 and later crashed 68.94% in 2024.
  • Phibro Animal Health's Short term Debt stood at $13.1 million in 2021, then grew by 17.49% to $15.4 million in 2022, then soared by 68.9% to $26.0 million in 2023, then crashed by 37.61% to $16.2 million in 2024, then increased by 27.0% to $20.6 million in 2025.
  • The last three reported values for Short term Debt were $20.6 million (Q4 2025), $18.4 million (Q3 2025), and $16.2 million (Q2 2025) per Business Quant data.